Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05231304 · ClinicalTrials.gov registry record
Retrospective Evaluation of Clinical and Radiographic Outcomes Following Total Talus Replacement
A clinical trial, sponsored by Restor3D.
- Completed
- Registry status
- 80
- Enrollment target
NCT05231304: Completed study, sponsored by Restor3D.
NCT05231304 is a clinical trial that has completed, run by Restor3D. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05231304 has completed, sponsored by Restor3D.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
This study is a retrospective analysis of patients who underwent surgery using a total talus replacement (TTR) implant with or without concurrent total ankle replacement and/or subtalar fusion. This study seeks to analyze the clinical and radiographic outcomes of TTR implant recipients and generate additional data on the safety and benefit of the TTR implant.
Primary Outcome
Primary probable benefit endpoint is improvement in pain at 12 months from preoperative baseline.
Interventions
- PROCEDURE Total Talus Replacement (TTR)
- PROCEDURE Total Ankle Total Talus Replacement (TATTR)
- PROCEDURE Total Ankle Total Talus Replacement + Subtalar Fusion (TATTR + STJ)
- PROCEDURE Total Talus Replacement + Subtalar Fusion (TTR + STJ)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2022-04-05 |
| Est. Completion | 2024-02-19 |
What the finished NCT05231304 record still lists
NCT05231304 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.
The record links to 0 conditions, and to 4 interventions - of which Total Talus Replacement (TTR) is the first listed.
NCT05231304 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05231304 about?
NCT05231304 is a clinical study titled "Retrospective Evaluation of Clinical and Radiographic Outcomes Following Total Talus Replacement". This study is a retrospective analysis of patients who underwent surgery using a total talus replacement (TTR) implant with or without concurrent total ankle replacement and/or subtalar fusion. This study seeks to analyze the clinical and radiographic outcomes of TTR implant recipients and generate ...
What is the current status of trial NCT05231304?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2022-04-05. Estimated completion is 2024-02-19.
What interventions are being tested in trial NCT05231304?
The interventions under investigation include: Total Talus Replacement (TTR) (PROCEDURE), Total Ankle Total Talus Replacement (TATTR) (PROCEDURE), Total Ankle Total Talus Replacement + Subtalar Fusion (TATTR + STJ) (PROCEDURE), Total Talus Replacement + Subtalar Fusion (TTR + STJ) (PROCEDURE).
Who is sponsoring clinical trial NCT05231304?
This trial is sponsored by Restor3D, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI